X0306 4 2020-04-21 0 0000001800 ABBOTT LABORATORIES ABT 0001328034 CAPEK JOHN M 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-6400 0 1 0 0 Executive Vice President Common shares without par value 2020-04-21 4 M 0 50100 22.3919 A 366900 D Common shares without par value 2020-04-21 4 S 0 31399 95.6314 D 335501 D Common shares without par value 2020-04-21 4 S 0 18701 96.2834 D 316800 D Option (right to buy) 22.3919 2020-04-21 4 M 0 50100 0 D 2014-02-18 2021-02-17 Common shares 50100 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.14 to $96.135, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.14 to $96.52, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Jessica H. Paik, by power of attorney for John M. Capek 2020-04-23